CDC and FDA Declares Joint Statement in Johnson & Johnson COVID vaccine

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are giving a second thought and declaring a pause on the Johnson & Johnson COVID vaccine this April 2021 for the safety of the people.

COVID19 vaccine is given top priority these days. People worldwide are trying all kinds of immune boosters to help them stay away from viruses. Pharma companies are giving in their best to come out with efficient vaccines and medicines that can help the general public. The governments of all countries worldwide are executing various plans that can help stop the spread of coronavirus.  Right from imposing restrictions to lockdown, the government has put in a lot of effort to curb coronavirus spread.

The authorization of the COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have gone ahead and given the green flag to COVID  vaccines for use by the general public worldwide. They have approved COVID vaccines under the Emergency Authorization Use for the betterment of the people. The  Food and Drug Administration (FDA) is working to address the concerns about vaccines among people, to protect and promote the health of the entire population. They are focussing on the strategies that address health disparity.

Side effects of the COVID vaccine are a major concern 

The use of the coronavirus vaccine has brought about a major concern of side effects in immunized people. The major fear of blood clots has been rising among the people about the coronavirus vaccine. This has been noticed in people receiving the Johnson & Johnson (J&J) vaccine which has been administered. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are reviewing data of the six cases reported by the USA  where cases of rare and severe blood clots in the individual have been seen after receiving the  Johnson & Johnson (J&J) vaccine. A type of blood clot called Cerebral Venous Sinus Thrombosis(CVST) was seen in a combination of low platelet count, Thrombocytopenia. 

Details of the six cases detected an under review by The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)

All six cases which are under review were seen in the age group between 18 - 48. The symptoms of the blood clot called Cerebral Venous Sinus Thrombosis(CVST) and Thrombocytopenia occurred between 6 - 13 days after vaccination. Administering the COVID vaccine is led to this side effect of blood clots which needs immediate medical attention by The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The general conventional treatment of administering the anticoagulant called heparin is used to treat blood clots may be dangerous. We need to make sure that the vaccine has no interactions with the conventional treatment that is used by the patients. 

FDA ensures efficacy and safety of COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)  will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) to further review these six cases of blood clot side effects with COVID vaccine that has come into light this April 2021. FDA will review the analysis and also instigate the cases. Until the process is complete and under review, The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are recommending a pause to the use of the vaccine which is the need of the hour. This is a very important announcement by the FDA to ensure that healthcare professionals are aware of the side effects of this vaccine.

Tags : #medicircle #myhealth #FDA #CDC #COVIDvaccine #COVIDvaccinesideeffects

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024